Skip to main content
Erschienen in: World Journal of Surgery 8/2018

16.01.2018 | Original Scientific Report

Indocyanine Green Retention Rates at 15 min Predicted Hepatic Decompensation in a Western Population

verfasst von: Bertrand Le Roy, Emilie Grégoire, Cyril Cossé, Badr Serji, Nicolas Golse, René Adam, Daniel Cherqui, Jean-Yves Mabrut, Yves-Patrice Le Treut, Eric Vibert

Erschienen in: World Journal of Surgery | Ausgabe 8/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

ICGR15 is widely used in Asia to evaluate the liver reserve before hepatectomy, but not in Western countries where patients are selected using the MELD score and/or platelet count. Postoperative liver failure is rare nowadays, but hepatic decompensation (HD), defined by 3-month postoperative ascites, impairs quality of life and survival. The aim of this study was to evaluate the relevance of indocyanine green retention rate at 15 min (ICGR15) before liver resection in Western countries, in order to predict HD.

Methods

This prospectively designed study included consecutive adult patients undergoing hepatectomy for hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC) in three French HPB centres.

Results

Between 2012 and 2014, 147 patients were included (80% of HCC and 20% of ICC). The Child–Pugh status was grade A for all patients. In the overall population and in F3/F4 patients (n = 83), ICGR15 (P = 0.02) and platelet counts (P = 0.02) were predictive of HD under multivariate analysis. Among F3/F4 patients undergoing minor hepatectomy with preoperative ICGR15 > 15%, the rate of HD was 36%. In the overall population, ICGR15 was predictive of HD (P = 0.02) and postoperative ascites (P = 0.03). The ROC curve identified a cut-off point of 15% as being associated with increased HD, with good accuracy for ICGR15 in the study population (AUROC 0.73), mainly before minor hepatectomy (AUROC 0.79).

Conclusions

In patients with HCC and ICC selected using the MELD score and platelet rate, an ICGR15 > 15% is a relevant, non-invasive and clearly accurate method to predict HD specially before minor hepatectomy.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Rahbari NN, Garden OJ, Padbury R et al (2011) Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery 149:713–724CrossRefPubMed Rahbari NN, Garden OJ, Padbury R et al (2011) Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery 149:713–724CrossRefPubMed
2.
Zurück zum Zitat Schreckenbach T, Liese J, Bechstein WO et al (2012) Posthepatectomy liver failure. Dig Surg 29:79–85CrossRefPubMed Schreckenbach T, Liese J, Bechstein WO et al (2012) Posthepatectomy liver failure. Dig Surg 29:79–85CrossRefPubMed
3.
Zurück zum Zitat Bruix J, Castells A, Bosch J et al (1996) Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology 111:1018–1022CrossRefPubMed Bruix J, Castells A, Bosch J et al (1996) Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology 111:1018–1022CrossRefPubMed
4.
Zurück zum Zitat Balzan S, Belghiti J, Farges O et al (2005) The “50–50 criteria” on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg 242:824–828 (discussion 828–29) CrossRefPubMedPubMedCentral Balzan S, Belghiti J, Farges O et al (2005) The “50–50 criteria” on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg 242:824–828 (discussion 828–29) CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Mullen JT, Ribero D, Reddy SK et al (2007) Hepatic insufficiency and mortality in 1059 noncirrhotic patients undergoing major hepatectomy. J Am Coll Surg 204:854–862 (discussion 862–64) CrossRefPubMed Mullen JT, Ribero D, Reddy SK et al (2007) Hepatic insufficiency and mortality in 1059 noncirrhotic patients undergoing major hepatectomy. J Am Coll Surg 204:854–862 (discussion 862–64) CrossRefPubMed
6.
Zurück zum Zitat Torzilli G, Belghiti J, Kokudo N et al (2013) A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL/AASLD recommendations? An observational study of the HCC East-West study group. Ann Surg 257:929–937CrossRefPubMed Torzilli G, Belghiti J, Kokudo N et al (2013) A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL/AASLD recommendations? An observational study of the HCC East-West study group. Ann Surg 257:929–937CrossRefPubMed
8.
Zurück zum Zitat Douard R, Lentschener C, Ozier Y et al (2009) Operative risks of digestive surgery in cirrhotic patients. Gastroentérol Clin Biol 33:555–564CrossRefPubMed Douard R, Lentschener C, Ozier Y et al (2009) Operative risks of digestive surgery in cirrhotic patients. Gastroentérol Clin Biol 33:555–564CrossRefPubMed
9.
Zurück zum Zitat Nanashima A, Tobinaga S, Abo T et al (2010) Reducing the incidence of post-hepatectomy hepatic complications by preoperatively applying parameters predictive of liver function. J Hepato Biliary Pancreat Sci 17:871–878CrossRef Nanashima A, Tobinaga S, Abo T et al (2010) Reducing the incidence of post-hepatectomy hepatic complications by preoperatively applying parameters predictive of liver function. J Hepato Biliary Pancreat Sci 17:871–878CrossRef
10.
Zurück zum Zitat Lee LJ-H, Chen C-H, Yao G et al (2007) Quality of life in patients with hepatocellular carcinoma received surgical resection. J Surg Oncol 95:34–39CrossRefPubMed Lee LJ-H, Chen C-H, Yao G et al (2007) Quality of life in patients with hepatocellular carcinoma received surgical resection. J Surg Oncol 95:34–39CrossRefPubMed
11.
Zurück zum Zitat Imamura H, Sano K, Sugawara Y et al (2005) Assessment of hepatic reserve for indication of hepatic resection: decision tree incorporating indocyanine green test. J Hepatobiliary Pancreat Surg 12:16–22CrossRefPubMed Imamura H, Sano K, Sugawara Y et al (2005) Assessment of hepatic reserve for indication of hepatic resection: decision tree incorporating indocyanine green test. J Hepatobiliary Pancreat Surg 12:16–22CrossRefPubMed
12.
Zurück zum Zitat Cucchetti A, Ercolani G, Vivarelli M et al (2006) Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. Liver Transpl 12:966–971CrossRefPubMed Cucchetti A, Ercolani G, Vivarelli M et al (2006) Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. Liver Transpl 12:966–971CrossRefPubMed
13.
Zurück zum Zitat Bruix J, Sherman M, Practice Guidelines Committee, American Association for the Study of Liver Diseases (2005) Management of hepatocellular carcinoma. Hepatol Baltim Md 42:1208–1236CrossRef Bruix J, Sherman M, Practice Guidelines Committee, American Association for the Study of Liver Diseases (2005) Management of hepatocellular carcinoma. Hepatol Baltim Md 42:1208–1236CrossRef
14.
Zurück zum Zitat Cucchetti A, Ercolani G, Vivarelli M et al (2009) Is portal hypertension a contraindication to hepatic resection? Ann Surg 250:922–928CrossRefPubMed Cucchetti A, Ercolani G, Vivarelli M et al (2009) Is portal hypertension a contraindication to hepatic resection? Ann Surg 250:922–928CrossRefPubMed
15.
Zurück zum Zitat Makuuchi M, Kosuge T, Takayama T et al (1993) Surgery for small liver cancers. Semin Surg Oncol 9(4):298–304CrossRefPubMed Makuuchi M, Kosuge T, Takayama T et al (1993) Surgery for small liver cancers. Semin Surg Oncol 9(4):298–304CrossRefPubMed
16.
Zurück zum Zitat Nonami T, Nakao A, Kurokawa T et al (1999) Blood loss and ICG clearance as best prognostic markers of post-hepatectomy liver failure. Hepatogastroenterology 46:1669–1672PubMed Nonami T, Nakao A, Kurokawa T et al (1999) Blood loss and ICG clearance as best prognostic markers of post-hepatectomy liver failure. Hepatogastroenterology 46:1669–1672PubMed
17.
Zurück zum Zitat Lisotti A, Azzaroli F, Buonfiglioli F et al (2014) Indocyanine green retention test as a noninvasive marker of portal hypertension and esophageal varices in compensated liver cirrhosis. Hepatology 59:643–650CrossRefPubMed Lisotti A, Azzaroli F, Buonfiglioli F et al (2014) Indocyanine green retention test as a noninvasive marker of portal hypertension and esophageal varices in compensated liver cirrhosis. Hepatology 59:643–650CrossRefPubMed
18.
Zurück zum Zitat Ohwada S, Kawate S, Hamada K et al (2006) Perioperative real-time monitoring of indocyanine green clearance by pulse spectrophotometry predicts remnant liver functional reserve in resection of hepatocellular carcinoma. Br J Surg 93:339–346CrossRefPubMed Ohwada S, Kawate S, Hamada K et al (2006) Perioperative real-time monitoring of indocyanine green clearance by pulse spectrophotometry predicts remnant liver functional reserve in resection of hepatocellular carcinoma. Br J Surg 93:339–346CrossRefPubMed
19.
Zurück zum Zitat Uesaka K, Nimura Y, Nagino M (1996) Changes in hepatic lobar function after right portal vein embolization. An appraisal by biliary indocyanine green excretion. Ann Surg 223:77–83CrossRefPubMedPubMedCentral Uesaka K, Nimura Y, Nagino M (1996) Changes in hepatic lobar function after right portal vein embolization. An appraisal by biliary indocyanine green excretion. Ann Surg 223:77–83CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Dindo D, Demartines N, Clavien P-A (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213CrossRefPubMedPubMedCentral Dindo D, Demartines N, Clavien P-A (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Pugh RN, Murray-Lyon IM, Dawson JL et al (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60:646–649CrossRefPubMed Pugh RN, Murray-Lyon IM, Dawson JL et al (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60:646–649CrossRefPubMed
22.
Zurück zum Zitat Kamath PS, Wiesner RH, Malinchoc M et al (2001) A model to predict survival in patients with end-stage liver disease. Hepatology 33:464–470CrossRefPubMed Kamath PS, Wiesner RH, Malinchoc M et al (2001) A model to predict survival in patients with end-stage liver disease. Hepatology 33:464–470CrossRefPubMed
23.
Zurück zum Zitat Lau H, Man K, Fan ST et al (1997) Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy. Br J Surg 84:1255–1259CrossRefPubMed Lau H, Man K, Fan ST et al (1997) Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy. Br J Surg 84:1255–1259CrossRefPubMed
25.
Zurück zum Zitat Torzilli G, Makuuchi M, Inoue K et al (1999) No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach. Arch Surg 134:984–992CrossRefPubMed Torzilli G, Makuuchi M, Inoue K et al (1999) No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach. Arch Surg 134:984–992CrossRefPubMed
26.
Zurück zum Zitat Umeda Y, Yagi T, Sadamori H et al (2008) Effects of prophylactic splenic artery modulation on portal overperfusion and liver regeneration in small-for-size graft. Transplantation 86:673–680CrossRefPubMed Umeda Y, Yagi T, Sadamori H et al (2008) Effects of prophylactic splenic artery modulation on portal overperfusion and liver regeneration in small-for-size graft. Transplantation 86:673–680CrossRefPubMed
27.
Zurück zum Zitat Ishizawa T, Hasegawa K, Aoki T et al (2008) Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Gastroenterology 134(7):1908–1916CrossRefPubMed Ishizawa T, Hasegawa K, Aoki T et al (2008) Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Gastroenterology 134(7):1908–1916CrossRefPubMed
28.
Zurück zum Zitat Yamazaki S, Takayama T, Nakamura M et al (2014) Prophylactic impact of endoscopic treatment for esophageal varices in liver resection: a prospective study. J Gastroenterol 49:917–922CrossRefPubMed Yamazaki S, Takayama T, Nakamura M et al (2014) Prophylactic impact of endoscopic treatment for esophageal varices in liver resection: a prospective study. J Gastroenterol 49:917–922CrossRefPubMed
29.
Zurück zum Zitat Silva-Junior G, Baiges A, Turon F et al (2015) The prognostic value of hepatic venous pressure gradient in patients with cirrhosis is highly dependent on the accuracy of the technique. Hepatol Baltim Md 62:1584–1592CrossRef Silva-Junior G, Baiges A, Turon F et al (2015) The prognostic value of hepatic venous pressure gradient in patients with cirrhosis is highly dependent on the accuracy of the technique. Hepatol Baltim Md 62:1584–1592CrossRef
30.
Zurück zum Zitat Steinlauf AF, Garcia-Tsao G, Zakko MF et al (1999) Low-dose midazolam sedation: an option for patients undergoing serial hepatic venous pressure measurements. Hepatology 29:1070–1073CrossRefPubMed Steinlauf AF, Garcia-Tsao G, Zakko MF et al (1999) Low-dose midazolam sedation: an option for patients undergoing serial hepatic venous pressure measurements. Hepatology 29:1070–1073CrossRefPubMed
31.
Zurück zum Zitat Reverter E, Blasi A, Abraldes JG et al (2014) Impact of deep sedation on the accuracy of hepatic and portal venous pressure measurements in patients with cirrhosis. Liver Int 34:16–25CrossRefPubMed Reverter E, Blasi A, Abraldes JG et al (2014) Impact of deep sedation on the accuracy of hepatic and portal venous pressure measurements in patients with cirrhosis. Liver Int 34:16–25CrossRefPubMed
Metadaten
Titel
Indocyanine Green Retention Rates at 15 min Predicted Hepatic Decompensation in a Western Population
verfasst von
Bertrand Le Roy
Emilie Grégoire
Cyril Cossé
Badr Serji
Nicolas Golse
René Adam
Daniel Cherqui
Jean-Yves Mabrut
Yves-Patrice Le Treut
Eric Vibert
Publikationsdatum
16.01.2018
Verlag
Springer International Publishing
Erschienen in
World Journal of Surgery / Ausgabe 8/2018
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-018-4464-6

Weitere Artikel der Ausgabe 8/2018

World Journal of Surgery 8/2018 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.